stars 1 stars 2 stars 3

Reynolds Therapeutics is a pharmaceutical/Medical Device company focused on development of NeuroRelease a novel neurological drug delivery systems for post-operative pain. Founder Frank Reynolds develops targeted delivery systems for drugs, devices, or biologics to treat pain, epilepsy, Parkinson’s disease, and spinal cord injury. Our lead product platform, NeuroRelease™, has achieved sustained therapeutic release of non-opiate drugs for post-operative, acute and chronic pain in pre-clinical models.

Reynolds Therapeutics Questions

The Reynolds Therapeutics annual revenue was $32.2 million in 2026.

1 people are employed at Reynolds Therapeutics.

Reynolds Therapeutics is based in Fort Myers, Florida.

The NAICS codes for Reynolds Therapeutics are [32, 32541, 3254, 325].

The SIC codes for Reynolds Therapeutics are [283, 2834, 28].

Learn More
How It Works
get free account
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups.
search page
Search the #1 Contact Database
Get contact details of over 700M profiles across 60M companies – all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
get contact page
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.
G2 Leader Winter 2026 G2 Leader Mid Market Winter 2026 G2 Leader Small Business Winter 2026 G2 Most Implementable Winter 2026 G2 Best Est ROI Mid Market Winter 2026 G2 Leader Momentum Winter 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2025
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users